Effects of MDR1 Gene Polymorphism on Efficacy and Hematotoxicity of Epirubicin-Based Regimen in Patients with Breast Cancer in Southwest China
Effects of MDR1 Gene Polymorphism on Efficacy and Hematotoxicity of Epirubicin-Based Regimen in Patients with Breast Cancer in Southwest China
Review Data
Q: Is the topic relevant to the journal area of interest? Is it contemporary and interesting for
researchers?
A: Very good
Abstract & Keywords
Q: Are all required components included in the abstract? Are the keywords appropriately chosen?
A: Very good
Goal
Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?
A: Good
Structure
Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?
A: Good
Comments:
A few minor errors have been noted in the manuscript:
- In Materials and Methods, the word “forward” has been misspelt under the subheading “The primer design of MDR1 gene SNP” throughout.
- In the 2nd sentence under “Statistical Analysis”, “clinical basic characteristics” should be reframed as “basic clinical characteristics”.
- In the 10th sentence of first paragraph of Discussion, the words “affects” and “attribute” should be changed to “affect” and “attributed” respectively.
· The heading “Conclussion” should be corrected to “Conclusion”.
Tools and Methods
Q: Are methods the author uses adequate and well used?
A: Very good
Discussion & Conclusion
Q: Is it related to the results presented before? Do you consider them as coherent?
A: Very good
Comments:
The Results are clearly explained and aptly supported by data. The study is well-executed, and the Conclusion provides an apt summary of the findings of the present study. It suggests that C3435T polymorphism may be a risk factor for grade III ~ IV leukopenia in breast cancer patients treated with Epirubicin regimen in Southwest China. Confirmation of the results are further required by large sample, multicenter clinical studies.
Literature
Q: Does the author utilize relevant literature?
A: Very good
Author's knowledge
Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?
A: Good
Length
Q: Is the length of the paper adequate to the significance of the topic? Do you suggest shortening the paper without losing its value?
A: Good
Figures & Tables
Q: Does the author use them suitably? Are legend and notations clear?
A: Excellent
Writing style
Q: Is it clear and understandable?
A: Good
Further comments on the paper
Comments: The study investigates the predictive value of multi-drug resistance gene (MDR1) polymorphism in the efficacy and hematological toxicity of chemotherapy regimen based on Epirubicin in patients with breast cancer in Southwest China. The fact that the incidence of breast cancer is ranked first place as a deadly disease among female cancer patients, makes the study significant. It includes patients who have received Epirubicin-based chemotherapy, and polymorphism of C1236T, G2677T/A and C3435T were detected by time-of-flight mass spectrometry (TOF-MS).
Q: Would you recommend this manuscript for further publication?
A: Yes - Suitable to be published
If you have any questions and clarifications you can write to the journal.
Thanks,
Science Repository Team
Science Repository This email is restricted to the intended user. |
Science Repository - Support |
Author Info
Qiming Wei Xiaoyan Zhong Wanlong Zhu Qingze Fan Zhigui Wu Changjing Xu Mengyang Li Chengbin Zhang Yuanzhi Liu JunYi Zhao Yilan Huang
Corresponding Author
Yilan HuangDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China
Article Info
Article Type
Research ArticlePublication history
Received: Mon 15, Mar 2021Accepted: Fri 19, Mar 2021
Published: Tue 30, Mar 2021
Copyright
© 2023 Yilan Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.COR.2021.04.04